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Introduction
Prior to the ‘‘genomic era,’’ when the
acquisition of DNA sequence involved
significant labor and expense, the sequenc-
ing of genes was strongly linked to the
experimental characterization of their
products. Sequencing at that time directly
resulted from the need to understand an
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experimentally determined phenotype or
biochemical activity. Now that DNA
sequencing has become orders of magni-
tude faster and less expensive, focus has
shifted to sequencing entire genomes.
Since biochemistry and genetics have
not, by and large, enjoyed the same
improvement of scale, public sequence
repositories now predominantly contain
putative protein sequences for which there
is no direct experimental evidence of
function. Computational approaches at-
tempt to leverage evidence associated with
the ever-smaller fraction of experimentally
analyzed proteins to predict function for
these putative proteins. Maximizing our
understanding of function over the uni-
verse of proteins in toto requires not only
robust computational methods of infer-
ence but also a judicious allocation of
experimental resources, focusing on pro-
teins whose experimental characterization
will maximize the number and accuracy of
follow-on predictions.
COMBREX (COMputational BRidges
to EXperiments, http://combrex.bu.edu)
is an NIH-funded enterprise that has
brought computational and experimental
biologists together, with the goal of greatly
improving our overall understanding of
microbial protein function [1,2]. Since its
inception, it has made significant progress
toward the following goals: identifying the
minority of proteins that have already
been experimentally characterized, serving
as a public repository of novel protein
function predictions made by diverse
methods, producing a clear chain of
evidence from experiment to prediction,
identifying (‘‘recommending’’) those func-
tional predictions whose verification will
contribute most to our overall understand-
ing of protein function, and actually
funding the experiments to test function.
The recommendation system is a proof of
concept based on active learning princi-
ples and includes, for a given protein,
criteria including phylogenetic distribution
of its protein family, biological and clinical
phenotypes associated with it, the avail-
ability of protein structure data, and its
sequence distance from experimentally
determined proteins or from the other
proteins in its family.
COMBREX comprises several interre-
lated efforts. First, the project is building a
community of researchers (the COMBREX
Community) committed to achieving the
goals above. Second, the project maintains
a web-accessible database (the COMBREX
Database) of known and predicted functions
for microbial proteins. The database
search features enable biologists to identify
predictions whose experimental verifica-
tion is particularly important. Finally, the
project issues small monetary awards
(COMBREX grants) to biologists to fund
the experimental testing of such predic-
tions. In this paper, we provide a brief
review of COMBREX, focusing on its
overall design, its computational resources,
and the experimental results from the first
phase of the project.
Overview of COMBREX
The activities of the COMBREX Com-
munity are summarized in Figure 1. As a
starting point, we identify those proteins
with experimentally confirmed functions (a
functional ‘‘ground truth’’). The COM-
BREX Community and its collaborators
have assembled and are in the process of
curating such a set, called the Gold
Standard Database (GSDB). This set of
known sequence-function relationships
will ultimately serve as the basis for
making predictions for similar proteins
whose functions have not been experi-
mentally determined and can be used to
train other types of prediction-generating
algorithms. Currently, the GSDB can be
selectively accessed through the COM-
BREX Database by searching for proteins
whose functions are experimentally deter-
mined.
The objectives of the COMBREX
Database are to act as a comprehensive
repository of protein function predictions
and experimental data, and to recommend
important predictions to researchers for
experimental analysis. Approximately 3.3
million proteins from more than 1,000
completely sequenced microbial genomes
are represented in the database, and these
are associated with about 2.5 million
predictions of function. The functional status
of each protein (that is, whether the
function is known through direct observa-
tion, through prediction, or not at all) is
summarized in Figure 2: experimentally
characterized proteins are designated green,
proteins with functional predictions blue,
and those with no available predictions
black (seeMaterials andMethods in Text S1
for further description of the color coding).
The small fraction of experimentally char-
acterized proteins is necessarily an under-
estimate because the GSDB is still a work in
progress, but we estimate the true number
is likely no more than ten-fold larger. The
fraction of proteins with at least one
computationally predicted function (76%)
is by far the largest category, although the
degree to which the prediction specifies a
precise function varies widely.
Predictive models learn the most about
a set of proteins through the experiment
that produces the maximum gain of
information over the entire set, and so
identifying such experiments is of critical
importance. Protein function predictions
within the COMBREX Database are
prioritized based on the expected infor-
mation to be gained by their experimental
testing. Information gained from experi-
ments can be defined formally using
probabilistic criteria [3], but can be
understood intuitively in terms of the
number of proteins for which predictions
can be made, and the accuracy of those
predictions, using the new experimental
evidence. The recommendation system
that performs the prioritization is intended
to provide guidance to experimental
researchers interested in applying for
COMBREX grants. These grants are
issued to biochemists and molecular biol-
ogists to enable the experiments needed to
characterize specific microbial proteins,
giving preference to those of ‘‘high prior-
ity’’ as identified by this system. The
results of successful experiments can then
be added to the GSDB, thereby complet-
ing the cycle depicted in Figure 1. COM-
BREX grants are dependent upon exter-
nal funding, and the first round of awards
was generously supported by the NIH
using a novel funding mechanism. COM-
BREX continues to seek additional sourc-
es of funding to enlarge the participating
community internationally.
COMBREX Grants: Experiments
Funded
Our funding model encourages the
experimental characterization of proteins
through small-scale funding of many
laboratories using grants directly managed
by COMBREX. Although high-through-
put methods may ultimately allow for the
study of many proteins simultaneously, at
present the most effective way to accu-
rately characterize protein function is
through the dedicated examination of
individual proteins. In order to maximize
the value of COMBREX grants, they are
preferentially issued to laboratories with
demonstrated experience in the proposed
assays. There are experimental and eco-
nomic efficiencies to be gained by this in
that these laboratories will typically al-
ready possess many of the reagents
required for the assay, including relevant
substrate libraries, as well as personnel
with the expertise to conduct the assays
rapidly. In addition, we advocate the
testing of several members of a given
protein family within a single grant
whenever possible, since once all the
necessary components are in place to test
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a single protein, there are only marginal
increases in cost and labor needed to test
multiple similar proteins. Importantly,
should these similar proteins demonstrate
different functions, this approach has the
potential to delineate functional boundar-
ies in sequence space, improving the
follow-on predictions for many other
proteins. All COMBREX grant applica-
tions are reviewed by an external panel of
scientists to ensure that the proposed work
is scientifically sound and that each
laboratory is well suited to the proposed
tasks.
In the first year of the project, COM-
BREX-funded and COMBREX-associat-
ed experimental efforts have initiated the
examination of 140 proteins. (Funded
teams can be found on the COMBREX
website, at http://combrex.bu.edu/
acknowledgments, and a complete list of
these proteins can be found in Table S1.)
In the ideal case that all of the proposed
experiments are successful, the potential
impact of these experiments in terms of
follow-on predictions would be significant:
the 140 proteins reside in Protein Clusters
containing in total more than 3,200
proteins (resulting in high-confidence pre-
dictions for these) and are similar to over
60,000 proteins with BLAST E-values less
than 1e-05 (resulting in lower-confidence
predictions for these). Furthermore,
among these 140 proteins are encoded
eight Pfam-defined domains of unknown
function (DUFs), resulting in novel predic-
tive insights for all other proteins contain-
ing these DUFs (a total of 1,610 in the
COMBREX Database). Finally, 37 of
these 140 proteins contain a total of 28
unique Pfam-defined domains shared with
human proteins, providing functional in-
sights that may impact human health.
Research on about half of these proteins
has been successfully completed, and
results for some have been published [4–
8], while research on the other half is still
in progress. For those results that have
been reported, 65% of proteins (44 of 68)
have been verified to have the predicted
function described in the COMBREX
grant proposal, while no activity was
observed for the remaining 24 (Table
S1). Nine manuscripts funded by these
COMBREX grants have been submitted
for publication or are in preparation. As
examples, we highlight the results of three
COMBREX grants in Text S1.
Connecting Function
Predictions with Experimental
Data
A major effort of COMBREX is to
make predictions of gene function trace-
able to their experimental underpinnings.
This knowledge is critical to any research-
er attempting to assess the probability that
a particular prediction is correct. Unfor-
tunately, this information has generally
not been maintained in most databases.
Indeed, it is frequently unclear whether an
annotated function describes the results of
an experiment performed on that protein
or is an inference made based upon
homology to some other protein on which
the experiment was performed.
In the COMBREX Database, this trace
should ideally make clear the method used
to generate the prediction, the input to the
method, and the confidence in the ,gene,
prediction. pairing as measured by the
method’s scoring scheme. In practice, this
is not always possible, particularly for
unsourced annotations imported from
public databases. However, direct com-
parison of such unsourced annotations
with COMBREX-supported GSDB-based
Figure 1. Schematic overview of the computational and experimental contributions of COMBREX and its users, and the
interrelationships of these contributions. Data and results specific to COMBREX are shown in boxes. External data imported into COMBREX are
also shown, with arrows indicating entry points into the cycle. Methodology employed by COMBREX and its users is shown in blue type, as it is used
to generate data. Not shown are two critical contributions to COMBREX: genome and cluster data imported from NCBI RefSeq and ProtClustDB,
respectively, and NIH funding, which enables the grants that COMBREX issues to experimental laboratories.
doi:10.1371/journal.pbio.1001638.g001
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similarity assessment can provide some
measure of confidence. For many unchar-
acterized proteins, COMBREX provides
predictions based on sequence similarity to
GSDB proteins: we note the GSDB
protein that is the source of the prediction,
the experimentally determined function,
the publication(s) describing those experi-
ments, and the degree of sequence simi-
larity. As additional proofs of concept, we
have explored similarities based upon
protein structure and protein domain
composition to assess the extent to which
the experimental data in the GSDB can
generate predictions for the remaining
uncharacterized proteins. Specifically, we
sought to determine the fractions of all
uncharacterized proteins (blue or black) that
can be related to experimentally charac-
terized proteins (green) through sequence
and domain-composition similarity under
various thresholds. Results of these analy-
ses, which are described in Text S1, show
that existing experimental information can
provide functional insight into more than
half of all uncharacterized proteins.
Prioritizing Predictions for
Experimental Testing
Given the enormous mismatch in the
rates of gene discovery by DNA sequenc-
ing and protein function confirmation by
experiment, there is a compelling motiva-
tion to identify those proteins for which
experimental results would be maximally
informative in terms of follow-on predic-
tive power. The COMBREX Database
attempts to prioritize predictions based on
the expected information to be gained by
their experimental testing. We envision
eventually employing a comprehensive
metric based on probabilistic functional
linkage [12–14] to assess ‘‘importance’’
using information theoretical principles.
Our current recommendation system is a
prototype that uses several relatively
simple criteria to identify ‘‘important’’
proteins and make funding decisions.
The first criterion is the functional status
of proteins assigned by COMBREX, with
the rationale being to focus on those that
have testable predicted functions but no
associated experimental evidence (blue
genes [Figure 2]). Second, when recom-
mending proteins to examine from within
a large family (cluster), COMBREX
recommends candidates based on two
properties: genome of origin and position
within the cluster. We have chosen two
‘‘focus organisms,’’ Escherichia coli K-12
MG1655 and Helicobacter pylori 26695, for
which we would like to obtain a large
amount of experimental evidence, and we
encourage confirming predictions from
genes in these two strains. If a cluster does
not contain a member from either of these
genomes, COMBREX recommends
gene(s) with the shortest average sequence
Figure 2. Definitions of COMBREX functional status symbols and fractions of microbial genes in COMBREX in each status category.
Experimentally characterized proteins are green. (Those in the green set that have been manually curated by the GSDB are also marked with a gold
‘‘G.’’) Proteins with functional predictions but no experimental evidence are blue. Proteins with no available functional predictions are black.
doi:10.1371/journal.pbio.1001638.g002
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distance to all other members of the
cluster, in an attempt to select a gene
most likely to be representative of the
family (see Materials and Methods in Text
S1). Third, we recommend proteins from
larger protein families over those from
smaller families, where a ‘‘family’’ is a
super-cluster as defined by ProtClustDB
(Materials and Methods in Text S1).
Under the assumption that families are
isofunctional, experimental evidence from
one protein is likely to have an impact on
our total understanding of protein function
that is proportionate to the size of its
family. This concept has been the subject
of one published list of proposed experi-
mental targets [15]. Finally, we recognize
that there are significant contributory
factors to ‘‘importance’’ that are indepen-
dent of family size or sequence similarity.
Examples of such factors might include
being a key member of a particular
biochemical pathway, having a biochem-
ical function not previously identified
experimentally, indicating functional di-
versification within a family previously
thought to be isofunctional, or being
associated with a phenotype of interest.
This last factor benefits greatly from
community input, and we encourage
Community members to nominate pro-
teins they believe to be important. A more
detailed discussion of prioritization criteria
can be found in Text S1.
Taking the above criteria into consid-
eration, COMBREX has identified 100
genes we believe are of high priority for
experimental analysis (http://combrex.bu.
edu/top100) and specifically encourage
proposals to characterize these proteins.
Toward a Gold Standard
Database
Experimental observations provide the
foundation on which all functional predic-
tions rest. In order to properly trace
predictions to experiments, as well as to
intelligently select maximally informative
proteins for future experimental testing,
one requires comprehensive knowledge of
the identities of previously characterized
proteins. In collaboration with NCBI,
JCVI, and UniProt, we have begun
assembling such a comprehensive set,
namely the GSDB. A schema for the
nomination and inclusion of genes in the
GSDB is shown in Figure S4. First,
candidate genes with functions that are
believed to be experimentally determined
are identified, either by importation from
other curated databases such as EcoCyc,
CharProtDB (JCVI) [16,17], REBASE,
and UniProtKB/Swiss-Prot, or by ‘‘nom-
ination’’ by COMBREX Community
members via the website. Once identified,
candidate genes are manually examined
by volunteer curators to see if they meet
the criteria for inclusion in the GSDB.
Two criteria must be met for a gene/
protein to meet the curation standards.
First, the biochemical function of the gene
product must have been determined
experimentally in a published work or
fully documented in a public database.
Second, the DNA and/or protein se-
quence of the precise protein whose
function was determined must also be
known and be publicly available. Typical-
ly, this involves knowing with some
precision the bacterial or archaeal strain
from which the experimentally determined
protein was isolated or cloned. These
criteria are specified to ensure an unam-
biguous correspondence between se-
quence and function.
At present, the GSDB is small but
growing; statistics are shown in Table 1.
While the total number of experimentally
characterized proteins is unknown, we
estimate the number to be well above
50,000. The open-source, collaborative
nature of COMBREX and partnering
databases, combined with extensive par-
ticipation from the scientific community at
large, will be required for comprehensive
identification of characterized proteins.
We encourage everyone to nominate the
proteins about which they have knowledge
using the simple submission form at the
COMBREX website (http://combrex.bu.
edu/gold_form; requires registration) and
to volunteer to help curate candidate
GSDB proteins.
A Community-Based Model
COMBREX was initiated in response
to a 2004 PLOS Biology editorial that
proposed a community-wide effort to
better understand the proteins encoded
in the genomes we are continuing to
sequence [1]. For success, the project
relies on community participation for
three major efforts: biochemical study of
proteins by experimental biologists, com-
putational function prediction by compu-
tational biologists, and manual curation of
experimental information in the GSDB.
The biochemical effort by COMBREX
is predicated on three principles: prioriti-
zation of experiments, parallelization of
effort, and dissemination of results. Since
we are limited to funding a relatively small
number of experiments, prioritization is
intended to guide us toward preferentially
funding those experiments that can tell us
the most not just about the specific
proteins under study, but about other
proteins for which these experimental
results can generate predictions. The
prioritization system, though rudimentary
in its current form, is formally grounded in
machine learning, specifically in active
learning theory [3,18,19] (see Text S1).
Dissemination of the experimental re-
sults of COMBREX grants involves up-
dating the GSDB, which leads directly to
the generation of computational functional
predictions for other proteins. The com-
munity of biologists relies heavily on gene
and protein ‘‘annotations’’ in public data-
bases for this predictive information, but
these have several long-recognized short-
comings: the process by which a given
annotation was generated is typically not
transparent, the information is not always
current with published literature, the error
rate among these annotations can be high,
and many lower-throughput methods of
functional inference are not utilized [20–
22]. Therefore, reliance on any one
database for the predictive evidence
COMBREX needs to effectively prioritize
proteins would be unwise. We have
therefore taken the approach not of
selecting or generating the single best
functional prediction for a given protein,
but rather serving as a repository of
predictions from many sources, which
can be compared and evaluated using
both statistical and biological criteria.
While we work closely with several groups
that specialize in benchmarking and
competition, we also seek to identify
methodologies that have complementary
capabilities. This approach opens the door
for the dissemination of results from
specialized algorithms for functional pre-
diction in a way not previously possible.
The emphasis on function predictions, the
documentation of evidence for these
predictions, and the prioritization of un-
characterized proteins for experimental
testing distinguish COMBREX from other
publicly available microbial genomics
resources such as IMG [23], SEED [24],
GOLD [25], BioCyc [26], and others,
each of which have their own unique
emphasis.
The GSDB project, which requires the
distillation of decades of published litera-
ture, also requires public participation
through what we envision to be a
crowdsourcing model. We have assembled
preliminary data through collaboration
with UniProt and with CharProtDB, a
partially curated set of proteins with
experimental evidence assembled by JCVI
to serve as a source of evidence for its
microbial genome annotation pipeline.
However, manual curation or wiki-style
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collaboration will ultimately be needed to
ensure the completeness of the informa-
tion and the precise linkage of sequence
and function. Our best hope for the
success of the fledgling GSDB is broad
participation from the experimental com-
munity in identifying characterized pro-
teins and performing the necessary cura-
tion.
The public participation encouraged
and required by COMBREX may have
the additional benefit of exposing younger
students to the biological sciences. The
small-scale grant model that COMBREX
has employed enables participation at the
undergraduate level for appropriately
equipped laboratories, since the necessary
assays are frequently straightforward, self-
contained in scope, and have technical
challenges that can easily be met by
beginning students with appropriate su-
pervision. Furthermore, curricula built
around teaching the techniques of cloning,
protein purification, and biochemical as-
say to multiple students can be readily
adapted to testing multiple related proteins
in parallel. As an example of COMBREX-
funded undergraduate participation, stu-
dents in one laboratory section at the
University of Virginia under the supervi-
sion of Linda Columbus were able to
successfully investigate biochemical activ-
ities and enzyme kinetics for three previ-
ously uncharacterized proteins: TM0441
(results of different substrates further
support the findings of Rodionova and
colleagues [27] [and see Text S1]) and
TM0542 from Thermotoga maritima, and
Ta0880 from Thermoplasma acidophilum
DSM1728 [28]. COMBREX hopes to
continue collaboration with this group
(http://biochemlab.org) and to replicate
these successes as part of an educational
component at numerous undergraduate
institutions.
Concluding Remarks
COMBREX is attempting to leverage
relatively scant experimental resources to
understand a large and growing collec-
tion of microbial proteins, the vast
majority of which will likely never be
directly functionally characterized. Com-
putational predictions must continue to
provide the basis for our understanding
of most proteins. It is imperative that
these predictions be as reliable as possi-
ble, and whenever possible, traceable to
the experiments that provided the evi-
dence for each prediction. When allocat-
ing experimental resources for this task,
not all proteins are of equal benefit. In
the most simplistic sense, characterization
of a judiciously chosen protein generates
or improves predictions for many other
proteins across many genomes, while
characterization of a protein related to
few or no other proteins (often referred to
as an ORFan [29,30]) may have a much
smaller impact. Despite the large number
of genome sequences already available,
new ORFans continue to appear at a
significant frequency, leading some to
estimate that the bacterial pan-genome
may be of infinite size [31]. This suggests
that a complete understanding of all
bacterial proteins may be impossible,
hence the need for prioritization. As an
alternative to complete understanding, as
proof of concept we adopted the twin
goals of pushing our overall understand-
ing toward the asymptote (by giving
priority to conserved genes) and working
toward the complete understanding of all
proteins in one or a few genomes (by
identifying ‘‘focus organisms’’). With
community participation on the experi-
mental, computational, and curatorial
sides, we feel these goals are within
reach.
Supporting Information
Figure S1 Pie charts showing relative
sequence similarity of uncharacterized
proteins in COMBREX to experimentally
characterized (green) proteins. (A) Blue
proteins. (B) Black proteins. Within each
pie, proteins are divided into those that
exhibit ‘‘strong’’ similarity, ‘‘weak’’ simi-
larity, or ‘‘no’’ similarity to characterized
proteins. Strong similarity requires a
BLASTP match of E#1e-05 along with
80% sequence identity along 80% of the
length of both query and hit, and identical
composition of domains as determined by
Pfam; these criteria are used by COM-
BREX to generate predictions, so all such
genes are blue by definition. Weak similar-
ity requires only a BLASTP match of
E#1e-05, with the aligned region covering
80% of the length of both query and hit,
with no other constraints; weak similarity
is not directly used to generate predictions
by COMBREX, hence a small portion of
black proteins satisfy these criteria. Con-
versely, as predictions for blue proteins
come from a number of sources, a
significant number of blue proteins do not
satisfy either the strong or weak sequence
similarity criteria and are categorized as
having no similarity to any characterized
protein.
(TIF)
Figure S2 Number of clusters as a
function of cluster size. Clusters are
broken down into three types based on
the functional status of their component
proteins: clusters containing $1 experi-
mentally characterized (green) gene are
represented by the green line; clusters
containing no experimentally character-
ized proteins but $1 protein with a
predicted function (blue) are represented
by the blue line; clusters where no proteins
have either a characterized or predicted
Table 1. Summary statistics for the GSDB.
GSDB Status COMBREX Status No. Genes
Total records 13,665a
Curated, accepted (GSDB) green (marked with G) 164
Curated, rejected blue 26
Not yet curated (GSDB queue) green 13,475
Source of Records
UniProt 4,017
REBASE 1,058
COMBREX 16
CharProtDB 8,574
aOf these records, 10,969 are currently represented in the COMBREX Database. The remaining records are primarily eukaryotic proteins.
doi:10.1371/journal.pbio.1001638.t001
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function are represented by the black line.
Cluster sizes are grouped with a bin size of
10, and in several instances a pseudocount
of 1 was added to 0 values to ensure
continuous lines in logarithmic scale.
(TIF)
Figure S3 Domain composition of pro-
teins in COMBREX. All COMBREX
proteins were clustered into groups based
on identical domain composition. Along
the x-axis, groups are separated based on
the number of annotated Pfam domains
per protein (as defined by Pfam). (A)
Histogram, where the green portion of
each bar indicates the number of proteins
that have identical domain composition to
an experimentally characterized (green)
protein, the blue portion those that have
identical domain composition to a protein
with a predicted function (blue), and the
black portion all others. (B) Same data
shown in logarithmic scale, where the
green, blue, and black lines represent the
sizes of the green, blue, and black portions
of the histogram bars in part A.
(TIF)
Figure S4 Flowchart of GSDB construc-
tion. Source information includes external
databases such as UniProtKB and other
databases (‘‘Source DBs’’), and genes
nominated by users via the COMBREX
website. All entries originating outside of
UniProtKB must be assigned a unique
UniProtKB accession number before entry
into the process. All candidates with a
UniProtKB accession number enter the
GSDB curation queue. After examination
by COMBREX curators, genes may be
accepted into the GSDB if they meet the
Gold Standard criteria. Those not accept-
ed are returned to UniProt for additional
research, and so that the UniProtKB
records may be appropriately updated if
necessary. Contents of the GSDB are
visible in COMBREX as green proteins,
where curated Gold Standard proteins are
labeled with a gold ‘‘G,’’ and proteins
awaiting curation are not. Proteins failing
the curation process join the blue set, like
all other proteins with no definitive
experimental information.
(TIF)
Table S1 Summary of proteins exam-
ined by COMBREX-funded projects.
(XLSX)
Table S2 Association of structural data
with uncharacterized proteins.
(DOC)
Table S3 Format of functional descrip-
tions in COMBREX.
(DOC)
Table S4 Free-text strings analyzed by
GOCat.
(DOC)
Table S5 Function predictions submit-
ted to COMBREX by external groups.
(DOC)
Text S1 More detailed description of
the following topics: selected COM-
BREX-funded experimental results;
functional inference from existing ex-
perimental information; use of struc-
tured vocabulary; and prioritization of
genes for experimental characterization.
Materials and Methods, including the
following topics: the COMBREX web-
site; functional status of genes; cluster-
ing of genes; semantic analysis of free-
text functional descriptions; and calcu-
lation of sequence distances within
clusters.
(DOC)
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